Related Experiment Videos
New combination therapies for asthma.
1Pulmonary Division, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7020, USA. jdonohue@med.unc.edu
Current Opinion in Pulmonary Medicine
|February 27, 2001
Summary
Combination therapies offer significant clinical benefits for asthma management by combining medications with complementary actions. This approach effectively reduces asthma exacerbations and improves patient symptoms, supported by extensive clinical data.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Asthma management often requires combination therapy due to the complex pathophysiology of the disease.
- Different therapeutic agents possess complementary mechanisms of action beneficial for controlling asthma.
Purpose of the Study:
- To review the scientific rationale and clinical benefits of various combination therapies for asthma.
- To highlight the efficacy of combining different drug classes in improving asthma control and reducing exacerbations.
Main Methods:
- Review of scientific literature and clinical trial data on asthma combination therapies.
- Analysis of the complementary mechanisms of action for different asthma medications.
Main Results:
- Combination of long-acting beta(2)-agonists and inhaled corticosteroids effectively reduces asthma exacerbations and improves symptoms.
- Inhaled corticosteroids combined with leukotriene-receptor antagonists or antihistamines offer additional therapeutic benefits.
- Older agents like theophylline and controlled-release albuterol can be added to inhaled corticosteroids to potentially reduce steroid dosage.
Conclusions:
- Combination therapy is a valuable strategy in asthma treatment, leveraging complementary mechanisms for enhanced efficacy.
- Ongoing research continues to explore novel combination approaches for improved asthma control.